SCHEMBL5897239

SCHEMBL5897239

O=C(Nc1ccc(Cl)c(NC(=O)c2ccc(Cl)nc2)c1)c1cc(F)cc(N2CCOCC2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.66
MAPK14 Q16539 11/20 0.59
MAPK13 O15264 1/20 0.59
MAPK12 P53778 1/20 0.59
MAPK11 Q15759 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.55
KDM4E B2RXH2 1/20 0.55
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ALDH1A1 P00352 2/20 0.54
GAA P10253 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HTT P42858 2/20 0.52
HPGD P15428 1/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5897317 0.91 MAPK14 (0.66) MAPTMAPK14TDP1
SCHEMBL2970080 0.91 MAPT (0.65) MAPTMAPK14MAPK13MAPK12MAPK11
SCHEMBL27545834 0.89 MAPT (0.60) MAPTMAPK14MAPK13MAPK12MAPK11
SCHEMBL5897206 0.82 MAPT (0.62) MAPTMAPK14MAPK13MAPK12MAPK11
SCHEMBL7850678 0.82 MAPT (0.60) MAPTMAPK14SMN1; SMN2KDM4EALDH1A1
SCHEMBL5897191 0.80 CSF1R (0.74) MAPTMAPK14ALDH1A1GAATDP1
SCHEMBL5896970 0.80 MAPK14 (0.59) MAPTMAPK14MAPK13MAPK12MAPK11
SCHEMBL401818 0.79 KCNQ3 (0.71) MAPTSMN1; SMN2RAB9A
SCHEMBL2980968 0.79 KCNQ3 (0.52) MAPTMAPK14MAPK13MAPK12MAPK11
SCHEMBL5897677 0.78 MAPK14 (0.63) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7060700-B2 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB (SE) 2006-06-13 US disclosed
CN-1142912-C Amide derivs. useful as inhibitors of production of cytokines 2004-03-24 CN disclosed
US-20030105142-A1 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB 2003-06-05 US disclosed
US-6432949-B1 Amide derivatives useful as inhibitors of the production of cytokines ASTRAZENECA AB (SE) 2002-08-13 US disclosed
CN-1321150-A Amide derivs. useful as inhibitors of production of cytokines ASTRAZENECA AB (SE) 2001-11-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105142-A1 Amide derivatives useful as inhibitors of the production of cytokines IL6, IL6ST, IL2 MAPT 4663/4885MAPK14 2563/4885MAPK13 3605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.